Microbiome-targeted Diet Therapy in Ulcerative Colitis

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Minnesota

About this trial

The central objective of this proposal is to test a novel diet capable of meeting the elevated protein requirements in ulcerative colitis (UC), while simultaneously decreasing microbial hydrogen sulfide (H2S) production in the colon with fiber.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Ability and willingness to provide informed consent

Age at least 18 years old

Diagnosis of UC based on clinical and endoscopic criteria

UC duration of at least 3 months

Disqualifiers

Moderate or severe UC as defined by UCEIS ≥5

History of stomach surgery or bowel resection

Antibiotic use within 3 months

Anticipated antibiotic exposure during the study period (e.g. perioperative antibiotics)

Trial design

Design model

Crossover

Treatments tested in this trial

  • High Protein, High Fiber (HPHF) Diet

    Other intervention

    The HPHF diet is a diet designed to maximize the intake of proteins and fermentable dietary fibers. Frozen meals are provided to participants weekly and consumed over two non-consecutive 7-day periods.

Treatment groups

40 Participants
are divided into 1 treatment group
Group A: On-Off Cycling InterventionExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Fecal H2S Production

Assessed from stool samples

Time frame
Week 4

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.